Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: KAIVA STRATEGIES, LLC
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2023-09-05 to 2025-06-15
Current total value of award: $9594482
Description: CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) OFFICE OF NEW DRUGS (OND) - WRITER/EDITOR SUPPORT SERVICES - TO CANCEL THE TERMINATION FOR CONVENIENCE IN ITS ENTIRETY